PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsObama puts $215 million price tag on precision medicine plan

BioNews

Obama puts $215 million price tag on precision medicine plan

Published 6 February 2015 posted in News and appears in BioNews 789

Author

Dr Nikki Davis

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.

The US President, Barack Obama, has revealed details of a multi-agency personalised medicine research plan...

The US President, Barack Obama, has revealed details of a multi-agency personalised medicine research plan.

The $215 million Precision Medicine Initiative will be used to collect and analyse health related data from a large number of people in order to relate underlying genetic information to health and treatment response.

In his State of the Union Address, President Obama said that the initiative would give Americans 'access to the personalised information we need to keep ourselves and our families healthier'.

Under the plan, the US National Institutes of Health (NIH) will receive $130 million to create a database containing health information from one million or more volunteers in the USA. This 'biobank' will include genetic, medical and microbiotic data from both healthy and sick volunteers with the aim that it will be used to accelerate medical research and to 'personalise' treatments to patients.

'Most medical treatments have been designed for the "average patient"', a White House statement said. 'As a result of this "one-size-fits-all" approach, treatments can be very successful for some patients, but not for others.'

'Personalised' medicine instead tailors treatments to take into account individual variability, so that healthcare decisions can be informed by a person's genetics.

Similar biobanks already exist in several countries, including Japan and the UK, and research into the genetics of diseases has in recent years resulted in the use of cancer gene testing to guide the treatment of patients with certain mutations (see BioNews 741 and 773).

The new funding initiative also includes $70 million to be given to the US National Cancer Institute to expand research into genetic mutations associated with cancers and to develop more effective approaches to treating the disease.

Funding will also be given to the US Food and Drug Agency to maintain necessary databases, and the Office of the National Coordinator for Health Information Technology to develop standards to ensure privacy and security of the information.

Many of the finer details of the Precision Medicine Initiative are as yet undecided. The director of the NIH, Dr Francis Collins, states that input is now needed from a range of healthcare professionals to 'help us put real specifics into what is now an exciting but somewhat general plan'.

Related Articles

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
12 June 2017 • 2 minutes read

FDA gives go-ahead to first cancer drug based on genetics

by Shaoni Bhattacharya

The first cancer drug based on a specific genetic feature has been approved by the US drugs regulator...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
28 September 2015 • 3 minutes read

NHS England sets out personalised medicine strategy

by Kirsty Oswald

NHS England's national medical director, Sir Bruce Keogh, has outlined how the organisation's approach to personalised medicine will develop over the coming years and expand beyond the work of the 100,000 Genomes Project...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
9 January 2015 • 2 minutes read

Genomics England announces 11 centres spearheading 100,000 Genomes Project

by Dr Barbara Kramarz

Eleven NHS Genomic Medicine Centres have been announced by Genomics England to spearhead the 100,000 Genomes Project...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
21 November 2014 • 3 minutes read

Genomics England launches 100,000 genomes collaboration

by David Gerard O'Rourke

Genomics England is inviting applications from UK researchers, NHS clinicians and those in scientific training to access the data compiled by its DNA sequencing project, the 100,000 Genomes Project....

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
29 September 2014 • 2 minutes read

Personalised treatment on horizon for rare genetic disease patients

by Siobhan Chan

UK researchers have identified the most serious genetic mutations responsible for a rare condition that causes blindness, opening the door for personalised treatment and tailored gene therapies...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
Reviews
10 March 2014 • 5 minutes read

Event Review: Genetics and the Prospect of Personalised Medicine for Obesity

by Dr Jamie Heather

The media likes to push the idea that the obesity epidemic is fuelled entirely by our increasingly well-fed and sedentary lives, which makes the opportunity to hear solid evidence for the other side of the equation refreshing...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
10 January 2014 • 2 minutes read

New York State launches genomic medicine project with $105 million

by Daryl Ramai

The New York State Governor, Andrew Cuomo, has announced a US$105 million partnership between the New York Genome Center (NYGC) and the University of Buffalo (UB) to accelerate genomic research in the region....

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
23 January 2013 • 2 minutes read

US National Institutes of Health put $416 million into personalised medicine

by Mehmet Fidanboylu

The National Institutes of Health (NIH) in the US has demonstrated its intent to make personalised medicine a reality by outlining plans for projects set to cost almost half a billion US dollars...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« MPs vote overwhelmingly in favour of mitochondrial donation

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.

Find out how you can advertise here
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

1 August 2022 • 2 minutes read

First UK medical guidelines issued for trans fertility preservation

1 August 2022 • 2 minutes read

Male age has more impact on IVF birth rate than previously thought

8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Complex structures of the human heart bioengineered

8 August 2022 • 1 minute read

Brain tumour gene also linked to childhood cancers

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856